BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28824882)

  • 1. Purinergic Signaling: A Common Path in the Macrophage Response against
    Petit-Jentreau L; Tailleux L; Coombes JL
    Front Cell Infect Microbiol; 2017; 7():347. PubMed ID: 28824882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular adenosine triphosphate affects the response of human macrophages infected with Mycobacterium tuberculosis.
    Dubois-Colas N; Petit-Jentreau L; Barreiro LB; Durand S; Soubigou G; Lecointe C; Klibi J; Rezaï K; Lokiec F; Coppée JY; Gicquel B; Tailleux L
    J Infect Dis; 2014 Sep; 210(5):824-33. PubMed ID: 24604822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances.
    Leng J; Butcher BA; Denkers EY
    Parasite Immunol; 2009 Dec; 31(12):717-28. PubMed ID: 19891610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages.
    Corrêa G; Marques da Silva C; de Abreu Moreira-Souza AC; Vommaro RC; Coutinho-Silva R
    Microbes Infect; 2010 Jun; 12(6):497-504. PubMed ID: 20298798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Complexity of Purinergic Signaling During Toxoplasma Infection.
    Moreira-Souza ACA; Coutinho-Silva R
    Curr Top Med Chem; 2021; 21(3):205-212. PubMed ID: 33319661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections.
    Buzoni-Gatel D; Schulthess J; Menard LC; Kasper LH
    Cell Microbiol; 2006 Apr; 8(4):535-44. PubMed ID: 16548880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.
    Mahamed DA; Toussaint LE; Bynoe MS
    Infect Immun; 2015 Feb; 83(2):721-9. PubMed ID: 25452548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii.
    Yamamoto M; Okuyama M; Ma JS; Kimura T; Kamiyama N; Saiga H; Ohshima J; Sasai M; Kayama H; Okamoto T; Huang DC; Soldati-Favre D; Horie K; Takeda J; Takeda K
    Immunity; 2012 Aug; 37(2):302-13. PubMed ID: 22795875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKCα.
    Koh HJ; Kim YR; Kim JS; Yun JS; Jang K; Yang CS
    PLoS Pathog; 2017 Jan; 13(1):e1006126. PubMed ID: 28125719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1.
    Ting LM; Kim AC; Cattamanchi A; Ernst JD
    J Immunol; 1999 Oct; 163(7):3898-906. PubMed ID: 10490990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrimidinergic Receptor Activation Controls Toxoplasma gondii Infection in Macrophages.
    Moreira-Souza AC; Marinho Y; Correa G; Santoro GF; Coutinho CM; Vommaro RC; Coutinho-Silva R
    PLoS One; 2015; 10(7):e0133502. PubMed ID: 26192447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
    Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
    Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors and their role in host resistance to Toxoplasma gondii.
    Yarovinsky F
    Immunol Lett; 2008 Aug; 119(1-2):17-21. PubMed ID: 18617274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of pathogenic mycobacteria with the host immune system.
    Houben EN; Nguyen L; Pieters J
    Curr Opin Microbiol; 2006 Feb; 9(1):76-85. PubMed ID: 16406837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of host-pathogen modulators of autophagy during Mycobacterium Tuberculosis infection and therapeutic repercussions.
    Khan A; Jagannath C
    Int Rev Immunol; 2017 Sep; 36(5):271-286. PubMed ID: 28976784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunobiology of the innate response to Toxoplasma gondii.
    Miller CM; Boulter NR; Ikin RJ; Smith NC
    Int J Parasitol; 2009 Jan; 39(1):23-39. PubMed ID: 18775432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.
    Shen P; Li Q; Ma J; Tian M; Hong F; Zhai X; Li J; Huang H; Shi C
    BMC Microbiol; 2017 Aug; 17(1):185. PubMed ID: 28835201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages.
    Lees MP; Fuller SJ; McLeod R; Boulter NR; Miller CM; Zakrzewski AM; Mui EJ; Witola WH; Coyne JJ; Hargrave AC; Jamieson SE; Blackwell JM; Wiley JS; Smith NC
    J Immunol; 2010 Jun; 184(12):7040-6. PubMed ID: 20488797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.
    Khan IA; Hakak R; Eberle K; Sayles P; Weiss LM; Urban JF
    Infect Immun; 2008 Mar; 76(3):1305-13. PubMed ID: 18195022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.